TipRanks
Advertisement
Advertisement
Tyra Biosciences files automatic mixed securities shelf
PremiumThe FlyTyra Biosciences files automatic mixed securities shelf
1M ago
Tyra Biosciences price target lowered to $30 from $45 at H.C. Wainwright
Premium
The Fly
Tyra Biosciences price target lowered to $30 from $45 at H.C. Wainwright
1M ago
Midday Fly By: Analog acquires Alif, Independence Realty merges with Centerspace
Premium
The Fly
Midday Fly By: Analog acquires Alif, Independence Realty merges with Centerspace
1M ago
Tyra Biosciences: Buy Rating Reiterated as SURF302 Data Upside Beckons; 12‑Month Price Target Maintained at $45
PremiumRatingsTyra Biosciences: Buy Rating Reiterated as SURF302 Data Upside Beckons; 12‑Month Price Target Maintained at $45
2M ago
Tyra Biosciences: Buy Rating Reiterated as Dabogratinib Outlook Strengthens and $50 Price Target Remains Unchanged
Premium
Ratings
Tyra Biosciences: Buy Rating Reiterated as Dabogratinib Outlook Strengthens and $50 Price Target Remains Unchanged
2M ago
John Newman Maintains Buy Rating on Tyra with Unchanged $50 Price Target, Citing Dabogratinib’s Strong Growth Potential and Safety Profile in Achondroplasia
Premium
Ratings
John Newman Maintains Buy Rating on Tyra with Unchanged $50 Price Target, Citing Dabogratinib’s Strong Growth Potential and Safety Profile in Achondroplasia
2M ago
Analyst Reiterates Buy on Tyra, Maintaining $45 Price Target Ahead of Key SURF302 Phase 2 Readout
PremiumRatingsAnalyst Reiterates Buy on Tyra, Maintaining $45 Price Target Ahead of Key SURF302 Phase 2 Readout
3M ago
Tyra Biosciences: Boris Peaker Reaffirms Buy Rating with $56 Price Target on Strength of FGFR3 Pipeline and Upcoming SURF-302/BEACH-301 Data
Premium
Ratings
Tyra Biosciences: Boris Peaker Reaffirms Buy Rating with $56 Price Target on Strength of FGFR3 Pipeline and Upcoming SURF-302/BEACH-301 Data
3M ago
Tyra Biosciences reports Q2 EPS (69c), consensus (64c)
Premium
The Fly
Tyra Biosciences reports Q2 EPS (69c), consensus (64c)
3M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―